Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -8,609.19%-1.73M | -1,468.26%-819.32K | -5,260.20%-1.95M | -164.02%-1.07M | -392.21%-964.9K | 75.45%-19.86K | 53.81%-52.24K | -120.40%-36.37K | -366.94%-406.55K | -1,048.77%-196.04K |
| Net income from continuing operations | -7,367.15%-5.77M | -2,555.82%-1.52M | -2,838.76%-1.87M | -19.27%-747.72K | -195.67%-549.5K | 48.33%-77.32K | 78.63%-57.19K | -167.32%-63.71K | -172.15%-626.91K | -424.26%-185.85K |
| Remuneration paid in stock | --3.97M | -42.84%5.14K | --411.81K | ---- | ---- | --0 | --9K | --0 | -92.48%4.5K | --4.5K |
| Other non cashItems | ---- | ---- | -101.89%-630 | -93.10%15.5K | -111.37%-12K | ---- | ---- | 934.20%33.37K | 447.56%224.5K | 559.38%105.5K |
| Change In working capital | 117.62%74.98K | 17,248.25%694.5K | -1,890.26%-489.33K | -8,144.44%-341.16K | -244.81%-398.89K | -32.08%34.46K | -107.57%-4.05K | 272.99%27.33K | -109.74%-4.14K | -388.41%-115.69K |
| -Change in receivables | -8,513.53%-43.93K | -1,933.07%-30.92K | -1,727.53%-21.64K | -158.91%-27.12K | -3,170.31%-23.91K | 89.60%-510 | 62.37%-1.52K | -48.19%-1.18K | -142.76%-10.48K | 83.06%-731 |
| -Change in prepaid assets | --91.67K | --870.91K | -3,466.15%-246.84K | -3,583.57%-789.62K | -7,345.03%-796.95K | --0 | --0 | --7.33K | 175.56%22.67K | --11K |
| -Change in payables and accrued expense | -22.11%27.24K | -5,652.63%-145.48K | -1,142.55%-220.85K | 3,012.35%475.59K | 7,172.85%421.97K | -35.21%34.97K | 96.51%-2.53K | 160.66%21.18K | -121.27%-16.33K | -138.27%-5.97K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -11,160.72%-1.73M | -1,467.06%-818.69K | -5,261.93%-1.95M | -164.02%-1.07M | -394.50%-969.4K | 81.01%-15.36K | 52.12%-52.24K | -77.40%-36.37K | -366.94%-406.55K | -1,048.77%-196.04K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -5.24K | 0 | ||||||||
| Net PPE purchase and sale | ---5.24K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---5.24K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 6.59M | 23.98K | 2.58M | 224.18%1.59M | 1,221.43%1.59M | 0 | 0 | 0 | 507.60%489.1K | 200.00%119.99K |
| Net common stock issuance | --6.53M | --0 | --2.53M | 303.73%1.49M | --1.49M | --0 | --0 | --0 | 6,151,916.67%369.11K | --0 |
| Proceeds from stock option exercised by employees | --59.53K | --23.98K | --47.38K | --25.17K | --25.17K | --0 | --0 | --0 | --0 | ---- |
| Net other financing activities | ---- | ---- | ---- | -41.48%70.22K | ---- | ---- | ---- | ---- | 200.00%119.99K | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --6.59M | --23.98K | --2.58M | 224.18%1.59M | 1,221.43%1.59M | --0 | --0 | --0 | 507.60%489.1K | 200.00%119.99K |
| Net cash flow | ||||||||||
| Beginning cash position | 1,671.98%387.07K | 1,590.94%1.25M | 463.69%622.66K | 295.69%110.46K | -96.52%6.48K | -91.83%21.84K | 899.57%74.09K | 295.69%110.46K | -88.12%27.92K | 46.58%186.51K |
| Current changes in cash | 31,731.76%4.86M | -1,557.05%-865.71K | 1,832.34%630.12K | 520.50%512.2K | 910.27%616.18K | 81.01%-15.36K | -120.09%-52.24K | -77.40%-36.37K | 139.87%82.55K | 23.44%-76.05K |
| End cash Position | 80,802.39%5.25M | 1,671.98%387.07K | 1,590.94%1.25M | 463.69%622.66K | 463.69%622.66K | -96.52%6.48K | -91.83%21.84K | 899.57%74.09K | 295.69%110.46K | 295.69%110.46K |
| Free cash from | -11,194.82%-1.73M | -1,602.94%-889.69K | -5,261.93%-1.95M | -164.02%-1.07M | -394.50%-969.4K | 81.01%-15.36K | 52.12%-52.24K | -77.40%-36.37K | -366.94%-406.55K | -1,048.77%-196.04K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.